ABS0115 ASSOCIATION OF IL-6 LEVELS WITH THE RISK OF DEVELOPING IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS | Publicación